226 related articles for article (PubMed ID: 33033376)
1. Author Correction: PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis.
Hou J; Zhao R; Xia W; Chang CW; You Y; Hsu JM; Nie L; Chen Y; Wang YC; Liu C; Wang WJ; Wu Y; Ke B; Hsu JL; Huang K; Ye Z; Yang Y; Xia X; Li Y; Li CW; Shao B; Tainer JA; Hung MC
Nat Cell Biol; 2020 Nov; 22(11):1396. PubMed ID: 33033376
[TBL] [Abstract][Full Text] [Related]
2. PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis.
Hou J; Zhao R; Xia W; Chang CW; You Y; Hsu JM; Nie L; Chen Y; Wang YC; Liu C; Wang WJ; Wu Y; Ke B; Hsu JL; Huang K; Ye Z; Yang Y; Xia X; Li Y; Li CW; Shao B; Tainer JA; Hung MC
Nat Cell Biol; 2020 Oct; 22(10):1264-1275. PubMed ID: 32929201
[TBL] [Abstract][Full Text] [Related]
3. Author Correction: Drug-induced PD-L1 expression and cell stress response in breast cancer cells can be balanced by drug combination.
Gilad Y; Eliaz Y; Yu Y; Han SJ; O'Malley BW; Lonard DM
Sci Rep; 2020 Mar; 10(1):4463. PubMed ID: 32132607
[TBL] [Abstract][Full Text] [Related]
4. Author Correction: High PD-L1 expression is associated with therapeutic response to pembrolizumab in patients with advanced biliary tract cancer.
Ahn S; Lee JC; Shin DW; Kim J; Hwang JH
Sci Rep; 2020 Dec; 10(1):21552. PubMed ID: 33273671
[TBL] [Abstract][Full Text] [Related]
5. Author Correction: Real-world evidence and clinical observations of the treatment of advanced non-small cell lung cancer with PD-1/PD-L1 inhibitors.
Song P; Zhang J; Shang C; Zhang L
Sci Rep; 2020 Jan; 10(1):1525. PubMed ID: 31988322
[TBL] [Abstract][Full Text] [Related]
6. Author Correction: Regulation of sister chromatid cohesion by nuclear PD-L1.
Yu J; Qin B; Moyer AM; Nowsheen S; Tu X; Dong H; Boughey JC; Goetz MP; Weinshilboum R; Lou Z; Wang L
Cell Res; 2020 Sep; 30(9):823. PubMed ID: 32636455
[TBL] [Abstract][Full Text] [Related]
7. Author Correction: Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance.
Zhang J; Bu X; Wang H; Zhu Y; Geng Y; Nihira NT; Tan Y; Ci Y; Wu F; Dai X; Guo J; Huang YH; Fan C; Ren S; Sun Y; Freeman GJ; Sicinski P; Wei W
Nature; 2019 Jul; 571(7766):E10. PubMed ID: 31270456
[TBL] [Abstract][Full Text] [Related]
8. Correction: Macrophage-derived CCL5 facilitates immune escape of colorectal cancer cells via the p65/STAT3-CSN5-PD-L1 pathway.
Liu C; Yao Z; Wang J; Zhang W; Yang Y; Zhang Y; Qu X; Zhu Y; Zou J; Peng S; Zhao Y; Zhao S; He B; Mi Q; Liu X; Zhang X; Du Q
Cell Death Differ; 2020 Jul; 27(7):2293. PubMed ID: 32024980
[TBL] [Abstract][Full Text] [Related]
9. Author Correction: Elevated numbers of PD-L1 expressing B cells are associated with the development of AIDS-NHL.
Epeldegui M; Conti DV; Guo Y; Cozen W; Penichet ML; Martínez-Maza O
Sci Rep; 2020 Jan; 10(1):748. PubMed ID: 31937870
[TBL] [Abstract][Full Text] [Related]
10. Author Correction: Early endosome autoantigen 1 regulates IL-1β release upon caspase-1 activation independently of gasdermin D membrane permeabilization.
Baroja-Mazo A; Compan V; Martín-Sánchez F; Tapia-Abellán A; Couillin I; Pelegrín P
Sci Rep; 2020 Dec; 10(1):21356. PubMed ID: 33262522
[TBL] [Abstract][Full Text] [Related]
11. Author Correction: Tumour lineage shapes BRCA-mediated phenotypes.
Jonsson P; Bandlamudi C; Cheng ML; Srinivasan P; Chavan SS; Friedman ND; Rosen EY; Richards AL; Bouvier N; Selcuklu SD; Bielski CM; Abida W; Mandelker D; Birsoy O; Zhang L; Zehir A; Donoghue MTA; Baselga J; Offit K; Scher HI; O'Reilly EM; Stadler ZK; Schultz N; Socci ND; Viale A; Ladanyi M; Robson ME; Hyman DM; Berger MF; Solit DB; Taylor BS
Nature; 2020 Jan; 577(7789):E1. PubMed ID: 31822847
[TBL] [Abstract][Full Text] [Related]
12. Gasdermins: Pore-forming Proteins as a Potential Therapeutic Target.
Jain K; Barve K; Bhatt LK
Curr Protein Pept Sci; 2022; 23(3):133-151. PubMed ID: 35538820
[TBL] [Abstract][Full Text] [Related]
13. Author Correction: Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression.
Rupaimoole R; Wu SY; Pradeep S; Ivan C; Pecot CV; Gharpure KM; Nagaraja AS; Armaiz-Pena GN; McGuire M; Zand B; Dalton HJ; Filant J; Miller JB; Lu C; Sadaoui NC; Mangala LS; Taylor M; van den Beucken T; Koch E; Rodriguez-Aguayo C; Huang L; Bar-Eli M; Wouters BG; Radovich M; Ivan M; Calin GA; Zhang W; Lopez-Berestein G; Sood AK
Nat Commun; 2020 Jun; 11(1):2867. PubMed ID: 32493919
[TBL] [Abstract][Full Text] [Related]
14. Author Correction: PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1
Verma V; Shrimali RK; Ahmad S; Dai W; Wang H; Lu S; Nandre R; Gaur P; Lopez J; Sade-Feldman M; Yizhak K; Bjorgaard SL; Flaherty KT; Wargo JA; Boland GM; Sullivan RJ; Getz G; Hammond SA; Tan M; Qi J; Wong P; Merghoub T; Wolchok J; Hacohen N; Janik JE; Mkrtichyan M; Gupta S; Khleif SN
Nat Immunol; 2019 Nov; 20(11):1555. PubMed ID: 31551574
[TBL] [Abstract][Full Text] [Related]
15. Author Correction: L1 drives IFN in senescent cells and promotes age-associated inflammation.
De Cecco M; Ito T; Petrashen AP; Elias AE; Skvir NJ; Criscione SW; Caligiana A; Brocculi G; Adney EM; Boeke JD; Le O; Beauséjour C; Ambati J; Ambati K; Simon M; Seluanov A; Gorbunova V; Slagboom PE; Helfand SL; Neretti N; Sedivy JM
Nature; 2019 Aug; 572(7767):E5. PubMed ID: 31296937
[TBL] [Abstract][Full Text] [Related]
16. Author Correction: Circulating Apolipoprotein L1 is associated with insulin resistance-induced abnormal lipid metabolism.
Nishimura K; Murakami T; Sakurai T; Miyoshi M; Kurahashi K; Kishi S; Tamaki M; Tominaga T; Yoshida S; Nagai K; Abe H; Hui SP; Kotani K; Doi T
Sci Rep; 2019 Dec; 9(1):20270. PubMed ID: 31882578
[TBL] [Abstract][Full Text] [Related]
17. Author Correction: Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer.
Färkkilä A; Gulhan DC; Casado J; Jacobson CA; Nguyen H; Kochupurakkal B; Maliga Z; Yapp C; Chen YA; Schapiro D; Zhou Y; Graham JR; Dezube BJ; Munster P; Santagata S; Garcia E; Rodig S; Lako A; Chowdhury D; Shapiro GI; Matulonis UA; Park PJ; Hautaniemi S; Sorger PK; Swisher EM; D'Andrea AD; Konstantinopoulos PA
Nat Commun; 2020 May; 11(1):2543. PubMed ID: 32424117
[TBL] [Abstract][Full Text] [Related]
18. Author Correction: DRP-1-mediated apoptosis induces muscle degeneration in dystrophin mutants.
Scholtes C; Bellemin S; Martin E; Carre-Pierrat M; Mollereau B; Gieseler K; Walter L
Sci Rep; 2020 Jul; 10(1):11665. PubMed ID: 32647220
[TBL] [Abstract][Full Text] [Related]
19. Author Correction: LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer.
Boulding T; McCuaig RD; Tan A; Hardy K; Wu F; Dunn J; Kalimutho M; Sutton CR; Forwood JK; Bert AG; Goodall GJ; Malik L; Yip D; Dahlstrom JE; Zafar A; Khanna KK; Rao S
Sci Rep; 2019 Dec; 9(1):18771. PubMed ID: 31801957
[TBL] [Abstract][Full Text] [Related]
20. Author Correction: Glis1 facilitates induction of pluripotency via an epigenome-metabolome-epigenome signalling cascade.
Li L; Chen K; Wang T; Wu Y; Xing G; Chen M; Hao Z; Zhang C; Zhang J; Ma B; Liu Z; Yuan H; Liu Z; Long Q; Zhou Y; Qi J; Zhao D; Gao M; Pei D; Nie J; Ye D; Pan G; Liu X
Nat Metab; 2020 Oct; 2(10):1179. PubMed ID: 33033400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
